Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orange Pearl Innovation Group is a Dutch-based venture builder and innovation hub specializing in the consumer healthcare, medtech, and personal care sectors. The company utilizes its proprietary Pearl System to rapidly transform innovative concepts into commercially successful global brands. Orange Pearl is known for developing high-impact products such as iWhite for oral care and Remescar for dermatology, which have achieved significant international market presence. Their business model integrates research and development, manufacturing, and global distribution strategies to ensure a fast speed-to-market for new healthcare solutions. While the company often spins off successful brands, such as the sale of Sylphar to Karo Healthcare, it continues to incubate new ventures like Cortiba Healthcare. Orange Pearl remains a key player in the European consumer health landscape, focusing on non-invasive and effective medical device and topical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orange Pearl Innovation Group.